Investigation of Ifosfamide Toxicity Induces Common Upstream Regulator in Liver and Kidney
Ifosfamide is an alkylating agent, a synthetic analogue of cyclophosphamide, used to treat various solid cancers. In this study, the toxicity of ifosfamide was evaluated using single-and multiple-dose intraperitoneal administration in rats under Good Laboratory Practice guidelines, and an additional...
Guardado en:
Autores principales: | Hyoung-Yun Han, Mi-Sun Choi, Seokjoo Yoon, Je-Won Ko, Sang-Kyum Kim, Tae-Won Kim |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a4790da033de4050841684db1455f04f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Safe decontamination of cytostatics from the nitrogen mustards family. Part one: cyclophosphamide and ifosfamide
por: Štenglová Netíková IR, et al.
Publicado: (2018) -
Ifosfamide/cyclofosfamide-induced methemoglobinemia in pediatric patients with hemoblastoses
por: Timur T. Valiev, et al.
Publicado: (2021) -
Assessment of the effect of antiretroviral therapy on renal and liver functions among HIV-infected patients: a retrospective study
por: Wondifraw Baynes H, et al.
Publicado: (2016) -
Could Mesna and Celery Seed Cotherapy Modulate Oxidative Stress and Inflammation of the Urinary Bladder Induced by Ifosfamide in Rabbits?
por: Mousa AM, et al.
Publicado: (2021) -
Doxorubicin/Adriamycin Monotherapy or Plus Ifosfamide in First-Line Treatment for Advanced Soft Tissue Sarcoma: A Pooled Analysis of Randomized Trials
por: Bi-Cheng Wang, et al.
Publicado: (2021)